| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/30/1997 | CA2224414A1 4,9-ethano-benzo(f)isoindole derivatives as farnesyl transferase inhibitors |
| 01/30/1997 | CA2224411A1 Novel farnesyl transferase inhibitors, preparation thereof and pharmaceutical compositions containing said inhibitors |
| 01/30/1997 | CA2223884A1 Polymeric lamellar substrate particles for drug delivery |
| 01/30/1997 | CA2223645A1 Antisense inhibition of hepatitis b virus replication |
| 01/30/1997 | CA2223472A1 Therapeutic agents |
| 01/30/1997 | CA2194504A1 Use of polyamine antagonists for the treatment of glaucoma |
| 01/29/1997 | EP0756008A2 Substrate for detection of mammalian 5-C-DNA methyltransferase |
| 01/29/1997 | EP0756005A1 Gene coding for adseverins |
| 01/29/1997 | EP0755934A1 Endothelin receptor antagonists |
| 01/29/1997 | EP0755932A1 (Thiophen-2-yl)piperidin or tetrahydropyridin-azabicyclocarboxamides |
| 01/29/1997 | EP0755931A1 Dihydropyridine and pyridine derivatives and process for their preparation |
| 01/29/1997 | EP0755930A1 Benzoxazepine derivatives, salts thereof, and drugs containing the same |
| 01/29/1997 | EP0755925A1 N,N'-di(aralkyl)-N,N'-di(2-azaaralkyl)alkylene-diamine derivatives and their use in pharmaceutical and cosmetic compositions |
| 01/29/1997 | EP0755922A1 22-thiavitamin d 3 derivative |
| 01/29/1997 | EP0755919A2 Substituted cinnamic acid guanidides, process for their preparation, their use as cardiovascualr medicament or diagnostic agent, as well as medicament containing them |
| 01/29/1997 | EP0755917A1 N,N'-di(aralkyl) N,N'-di(carboxyalkyl) alkylen- di- or triamino-derivatives and N-(aralkyl) N'-(carboxyalkyl) N,N'-di (carboxyalkyl) alkylen- di- or triamino-derivatives and their use in pharmacy and cosmetics |
| 01/29/1997 | EP0755688A1 Cellulose ester wound dressing |
| 01/29/1997 | EP0755685A1 Medicinal composition for treating tardive dyskinesia and utilization thereof |
| 01/29/1997 | EP0755683A1 Immunotherapy of tumor with monoclonal antibody against the 17-1A antigen |
| 01/29/1997 | EP0755680A2 Use of piperazine compounds as narcotic antagonists |
| 01/29/1997 | EP0755679A2 Use of Amtolmetin Guacil as an anti-inflammatory agent, which also inhibits gastric secretion |
| 01/29/1997 | EP0755678A1 Method and composition for a topical therapy of symptoms of the inner ear and the labyrinth |
| 01/29/1997 | EP0755675A1 Dermatological and/or pharmaceutical composition, process of preparation and utilization |
| 01/29/1997 | EP0755672A1 Silicon composition containing a water-sensitive agent |
| 01/29/1997 | EP0755633A1 Two phases preparation |
| 01/29/1997 | EP0755451A1 Materials and methods for management of hyperacute rejection in human xenotransplantation |
| 01/29/1997 | EP0755445A1 Cell-cycle regulatory proteins, and uses related thereto |
| 01/29/1997 | EP0755443A1 Tissue-specific enhancer active in prostate |
| 01/29/1997 | EP0755440A1 Novel mutated viruses, anti-viral compounds and novel methods of making vaccines |
| 01/29/1997 | EP0755399A1 Lobaplatinum trihydrate |
| 01/29/1997 | EP0755398A1 Process for the resolution of etodolac using glucamine derivatives |
| 01/29/1997 | EP0755396A1 Stable aqueous folinate solution |
| 01/29/1997 | EP0755394A1 A method of inducing cholecystokinin agonist activity using 1,4-benzodiazepine compounds |
| 01/29/1997 | EP0755393A1 Novel crystal forms of 1-[5-methanesulfonamidoindolyl-2-carbonyl]-4- 3-(1-methylethylamino)-2-pyridinyl]piperazine |
| 01/29/1997 | EP0755392A1 Alpha1c adrenergic receptor antagonists |
| 01/29/1997 | EP0755386A1 Benzamide derivative, compositions containing said derivative and use thereof |
| 01/29/1997 | EP0755385A1 Chelant compounds |
| 01/29/1997 | EP0755384A1 Cck or gastrin modulating 1,5 benzodiazepines derivatives |
| 01/29/1997 | EP0755383A1 Inhibitors of farnesyl-protein transferase |
| 01/29/1997 | EP0755382A1 Quinolone derivative for treatment of urinary incontinence |
| 01/29/1997 | EP0755381A1 Substituted pyridine leukotriene b 4 antagonists |
| 01/29/1997 | EP0755380A1 15-deoxyspergualin analogs, therapeutical use thereof, and method for preparing same |
| 01/29/1997 | EP0755372A1 Inhibitors of influenza virus neuraminidase and methods of making and using the same |
| 01/29/1997 | EP0755270A1 Microcapsules, method of making and their use |
| 01/29/1997 | EP0755265A1 The combination of growth hormone and insulin-like growth factor, for treating congestive heart failure |
| 01/29/1997 | EP0755263A1 Compositions and methods for stimulating megakaryocyte growth and differentiation |
| 01/29/1997 | EP0755262A1 Composition for the treatment of lung disease |
| 01/29/1997 | EP0755260A1 Phytotherapeutic agent for treatment of skin lesions and morbid changes in the skin and method for its preparation |
| 01/29/1997 | EP0755256A1 Starch-metal complexes for skin and hair |
| 01/29/1997 | EP0755255A1 Treatment of toxoplasmosis |
| 01/29/1997 | EP0755254A1 Prevention and treatment of ischemia-reperfusion and endotoxin-related injury using adenosine and purino receptor antagonists |
| 01/29/1997 | EP0755253A1 Intranasal antimigraine composition |
| 01/29/1997 | EP0755251A1 Low dosage ranitidine compositions for the treatment of minor gastrointestinal disorders associated with excess acid secretion |
| 01/29/1997 | EP0755250A1 Benzamide-containing pharmaceutical compositions |
| 01/29/1997 | EP0755249A1 Use of maillard reaction inhibitors for the treatment of amyloidosis-based disease |
| 01/29/1997 | EP0755246A1 Ophthalmic composition containing an ion sensitive, hydrophilic polymer and an inorganic salt in a ratio which gives low viscosity |
| 01/29/1997 | EP0755242A1 Use of galactosylglycerides and of naturally occurring extracts containing such products in cosmetics, pharmaceutics and particularly dermatology |
| 01/29/1997 | EP0727978A4 Topical aromatic releasing compositions |
| 01/29/1997 | EP0698012B1 Use of deoxygalactonojirimycin derivatives for inhibiting glycolipid synthesis |
| 01/29/1997 | EP0675878B1 Novel vitamin d analogues |
| 01/29/1997 | EP0666732B1 Cosmetic deodorant preparations containing di- or triglycerin esters |
| 01/29/1997 | EP0656777B1 Ready-to-inject azosemide solutions |
| 01/29/1997 | EP0655922B1 Antiproliferative oligomers |
| 01/29/1997 | EP0652755B1 Therapeutic use of phosphoryl-l-serine-n-acyl-sphingosine |
| 01/29/1997 | EP0651757B1 Novel acyclic amidine-group-containing diphosphonic acid derivatives, process for producing them and medicaments containing these compounds |
| 01/29/1997 | EP0651741B1 Ng-monomethyl-l-arginine hydrochloride derivatives and process for their preparation |
| 01/29/1997 | EP0641769B1 Amino acid derivative |
| 01/29/1997 | EP0635015B1 Acylaminoindole derivatives as 5-ht1 agonists |
| 01/29/1997 | EP0633878B1 Novel vitamin d analogues |
| 01/29/1997 | EP0597004B1 The use of dioxapyrrolomycin as an antiparasitic agent and compositions useful therefor |
| 01/29/1997 | EP0594726B1 Benzimidazole anthelmintic agents |
| 01/29/1997 | EP0594702B1 Substituted indoles as anti-aids pharmaceuticals |
| 01/29/1997 | EP0571491B1 Benzopyran phenol derivates for use as immunostimulating agents |
| 01/29/1997 | EP0544748B1 Spiro[cycloalkylbenzene-1,1'-(1',2',3',4'-tetrahydroisoquinolines)] having neuroprotective properties |
| 01/29/1997 | EP0501997B1 N-acyl-substituted azacyclic compounds, processes for their preparation, and their use as pharmaceuticals |
| 01/29/1997 | CN1141651A Endothelin-converting enzyme (ECE) |
| 01/29/1997 | CN1141634A Process and intermediates for preparing naphthycidonecarboxylic acid salts |
| 01/29/1997 | CN1141633A 4-heterocyclyl-substituted Quinazoline derivatives, method for prepn. of same and the use as anti-cancer agent |
| 01/29/1997 | CN1141632A 4-amino 6-substituted mycophenolic acid and derivatives with immunosuppressive activity |
| 01/29/1997 | CN1141631A Novel optionally substituted phenylimidazolidines, intermediates and process for prepn. thereof, use as drugs and pharmaceutical compositions contg. same |
| 01/29/1997 | CN1141630A Substituted pyrazolyl benzenesulfonamides for treating inflammation |
| 01/29/1997 | CN1141628A 2-(4-methoxyphenoxy)-3-pyridineamine its prepn. and its use as medicine |
| 01/29/1997 | CN1141627A Novel indol derivatives useful to treat estrogen-related neoplasms and disorders |
| 01/29/1997 | CN1141625A Vitamin D amine and amine derivatives |
| 01/29/1997 | CN1141590A Agent for prophylaxis and treatment of thromboxane A2-mediated diseases |
| 01/29/1997 | CN1141589A Film coated tablet of paracetamol and domperidone |
| 01/29/1997 | CN1141588A Injectable emulsions contg. antifungal triazole derivatives |
| 01/29/1997 | CN1141581A Compositions for administration to animals with coccidiosis |
| 01/29/1997 | CN1141300A Process for prepn. of ivermectin |
| 01/29/1997 | CN1141298A Pyrimidine-fused heterocyclic compound anti-cancer agents |
| 01/29/1997 | CN1141297A Pyrazolopyrimidines and pyrrolopyrimidines for treatment of neuronal and other disorders |
| 01/29/1997 | CN1141291A 4-(Arylaminomethylene)-2,4-dihydro-3-pyrazolones |
| 01/29/1997 | CN1141196A Application of quinoxalines in combination with protease inhibitors as medicaments |
| 01/29/1997 | CN1141191A Styracol tablet |
| 01/29/1997 | CN1141187A Medicine composition for curing cold |
| 01/29/1997 | CN1141168A Controlled release of steroids from sugar coattings |
| 01/29/1997 | CN1033914C Method for extrating kudzu vine root extract |
| 01/29/1997 | CA2182226A1 Dermatological or pharmaceutical composition; process for preparing and uses |
| 01/29/1997 | CA2182156A1 Endothelin-receptor-antagonists |
| 01/29/1997 | CA2180505A1 Substrate for detection of mammalian 5-c-dna methyltransferase |